All AMBIT and Retain6 Policy Briefs and Published Papers

Policy Briefs

Non-disclosure of prior antiretroviral therapy exposure among treatment initiators in South Africa, October 2024

Patterns of retention in care during clients’ first 12 months after HIV treatment initiation in Zambia, October 2024

PrEP for HIV-negative testers in Malawi: Offers and uptake as of May 2024, August 2024

How do less intensive differentiated models of care compare to conventional care for HIV treatment in South Africa? Retention in care and viral suppression, July 2024

Patterns of retention in care during clients’ first 12 months after HIV treatment initiation in South Africa, June 2023

Differentiated service delivery in Malawi: Provider and client costs of treatment, May 2024

CCMDD in South Africa: Provider workload, responsibilities, and time use (June 2023)

CCMDD in South Africa: Client satisfaction with CCMDD and conventional care, June 2023

The first six months of HIV treatment: clinic visit schedule and dispensing intervals at Zambian clinics, May 2022

Published Papers

Maskew M, Benade M, Huber A, Pascoe S, Sande L, Rosen S. Patterns of engagement in care during clients first 12 months after HIV treatment initiation in South Africa: a retrospective cohort analysis using routinely collected data. PLOS Global Public Health 2024; 4: e0002956.

Mokhele I, Huber A, Rosen S, Kaiser JL, Lekodeba N, Ntjikelane V, Hendrickson C, Scott N, Pascoe S. Satisfaction with service delivery among HIV treatment clients enrolled in differentiated and conventional models of care in South Africa: a baseline survey. J Int AIDS Soc 2024;27:e26233.

Benade M, Maskew M, Juntunen A, Rosen S. Prior exposure to antiretroviral therapy among adult patients presenting for HIV treatment initiation or re-initiation in sub- Saharan Africa: a systematic review. BMJ Open 2023; 13:e071283.doi:10.1136/bmjopen-2022-071283.

Benade M, Nichols B, Fatti G, Kuchukhidze S, Takarinda K, Mabhena-Ngorima N, Grimwood A, Rosen S. Economic evaluation of a cluster randomized, non-inferiority trial of differentiated service delivery models of HIV treatment in Zimbabwe. (Research supported by USAID/PEPFAR under EQUIP.) PLOS Global Public Health 2023; 3: e0000493.

Maskew M, Ntjikelane V, Juntenen A, Scott N, Benade M, Sande L, Haweeka P, Haimbe P, Lumano-Mulenga P, Shakewelele H, Mukumbwa-Mwenechanya M, Rosen S. Preferences for services in a patient’s first six months on antiretroviral therapy for HIV in South Africa and Zambia (PREFER): research protocol for a prospective observational cohort study. Gates Open Research 2023, 7:119.

Maskew M, Rosen S. Estimating the impact of differentiated models for HIV care (commentary). Lancet HIV 2023; 10: e628-29.

Jo Y, Jamieson L, Phiri B, Grimsrud A, Mwansa M, Shakwelele H, Haimbe P, Mukumbwa-Mwenechanya M, Mulano Mulenga P, Nichols BE, Rosen S. Attrition from HIV treatment after enrollment in a differentiated service delivery model: a cohort analysis of routine care in Zambia. PLOS One 2023; 18: e0280748

Maskew M, Sharpey-Schafer K, De Voux L, Crompton T, Bor J, Rennick M, Chirowodza A, Miot J, Molefi S, Onaga C, Majuba P, Sanne I, Pisa P. Applying machine learning and predictive modeling to retention and viral suppression in South African HIV treatment cohorts. Sci Rep. 2022 Jul 26;12(1):12715. doi: 10.1038/s41598-022-16062-0. PMID: 35882962; PMCID: PMC9325703.

Guthrie T, Muheke C, Rosen S, Kanoowe S; Lagony S; Greener R; Miot J; Balidawa H; Kiggundu J; Calnan J; Dejene S; Xulu T; Sigwebele N; Long L. Similar costs and outcomes for differentiated service delivery models for HIV treatment in Uganda. BMC Health Services Research (2022) 22:1315. (Research supported by USAID/PEPFAR under EQUIP.)

Rosen S, Nichols B, Guthrie T, Benade M, Kuchukhidze S, Long L. Do differentiated service delivery models for HIV treatment in sub-Saharan Africa save money? Synthesis of evidence from field studies conducted in sub-Saharan Africa in 2017-2019. Gates Open Research 2021, 5:177

Nichols BE, Rosen S. Economic evaluations of differentiated service delivery should include savings and ancillary benefits, not only health system costs: authors’ reply. AIDS 2021;35:2235-2236.

Ehrenkranz P, Rosen S, Boulle A, Eaton J, Fox MP, Ford N, Grimsrud A, Rice BD, Sikazwe I, Holmes C. The revolving door of HIV care: Revising the care cascade to achieve the 95-95-95 goals. PLOS Med 2021; 18: e1003651.

Nichols BE, Cele R, Lekodeba N, Tukei B, Norima-Mabhena N, Tiam A, Maotoe T, Sejana MV, Faturiyele I, Chasela C, Rosen S, Fatti G. Economic evaluation of a cluster randomized trial of differentiated service delivery models for HIV treatment in Lesotho: costs to providers and patients. J Int AIDS Soc 2021; 24: e25692. (Research supported by USAID/PEPFAR under EQUIP.)

Nichols BE, Cele R, Jamieson L, Long L, Siwale Z, Banda P, Moyo C, Rosen S. Community-based service delivery of HIV treatment in Zambia: costs and outcomes. AIDS 2021:299-306. PMID: 33170578. (Research supported by USAID/PEPFAR under EQUIP.)

Jamieson L, Rosen S, Phiri B, Grimsrud A, Mwansa M, Shakwelele H, Haimbe P, Mwenechanya MM, Lumano Mulenga P, Nichols BE. How soon should patients be eligible for differentiated service delivery models for antiretroviral treatment? Evidence from Zambia. BMJ Open 2022; 12:e064070. doi: 10.1136/bmjopen-2022-064070. 

Jo Y, Rosen S, Sy KTL, Phiri B, Huber AN, Mwansa M, Shakwelele H, Haimbe P, Mwenechanya MM, Lumano Mulenga P, Nichols BE. Changes in HIV treatment differentiated care uptake during the COVID-19 pandemic in Zambia: interrupted time series analysis. J Int AIDS Soc 2021;24 (Suppl6): e25808.

Huber A, Pascoe S, Nichols B, Long L, Kuchukhidze S, Phiri B, Tchereni T, Rosen S. Differentiated service delivery models for HIV treatment in Malawi, South Africa, and Zambia: a landscape analysis. Glob Heal Sci Pract 2021;9(2).

Hoffman RM, Moyo C, Balakasi K, Siwale Z, Hubbard J, Bardon A, Fox MP, Kakwesa G, Kalua T, Haambokoma M, Dovel K, Campbell P, Tseng C, Pisa TP, Cele R, Gupta S, Benade M, Long L, Xulu T, Sanne I, Rosen S. Multi-month dispensing of up to six months of antiretroviral therapy in Malawi and Zambia: Results of a cluster-randomized trial. Lancet Global Health 2021; 9: E628-E638. (Research supported by USAID/PEPFAR under EQUIP.)

Hoffman RM, Balakasi K, Bardon A, Siwale Z, Hubbard J, Kakwesa G, Maambokoma M, Kalua T, Pisa P, Moyo C, Dovel K, Xulu T, Sanne I, Fox MP, Rosen S, for EQUIP Health. Eligibility for differentiated models of HIV treatment service delivery: an estimate from Malawi and Zambia. AIDS 2020; 34:475–479. (Research supported by USAID/PEPFAR under EQUIP.)